Okyo Pharma Limited ADR (OKYO)
1.2200 -0.0500 (-3.94%) 12:18 ET [NASDAQ]
1.2000 x 10 1.2200 x 3
Realtime by (Cboe BZX)
1.2000 x 10 1.2200 x 3
Realtime - - (-) -
for Mon, Mar 31st, 2025
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
09-2024 | 03-2024 | 03-2023 | 09-2022 | 03-2022 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 987 | 827 | 4,045 | 746 | 2,701 |
Receivables | 1,840 | 711 | 1,151 | 1,119 | 1,595 |
Other current assets | 0 | 0 | 1 | 0 | -1 |
TOTAL | $2,827 | $1,538 | $5,197 | $1,866 | $4,295 |
Non-Current Assets | |||||
PPE Net | 2 | 11 | 15 | N/A | 10 |
TOTAL | $2 | $11 | $15 | $N/A | $10 |
Total Assets | $2,829 | $1,541 | $5,204 | $1,872 | $4,301 |
Liabilities | |||||
Current Liabilities | |||||
Short Term Debt | 2 | 0 | 2,215 | N/A | 0 |
Accounts payable and accrued liabilities | 10,053 | 7,062 | 4,263 | 2,104 | 1,306 |
Other current liabilities | N/A | 359 | 779 | 132 | 47 |
TOTAL | $10,055 | $7,421 | $7,257 | $2,236 | $1,353 |
Non-Current Liabilities | |||||
TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
Total Liabilities | $10,055 | $7,421 | $7,257 | $2,236 | $1,353 |
Shareholders' Equity | |||||
Retained earnings | -145,203 | -142,523 | -125,698 | -95,878 | -112,426 |
Other shareholders' equity | -6,073 | -6,470 | -7,741 | 2,859 | -8,604 |
TOTAL | $-7,226 | $-5,880 | $-2,053 | $-365 | $2,947 |
Total Liabilities And Equity | $2,829 | $1,541 | $5,204 | $1,872 | $4,300 |